About Plexium
Plexium is the premier, next-generation targeted protein degradation company, seeking to discover a wide range of monovalent target protein degraders that address the limitations of PROTACs and cereblon.
The company’s platform is a proprietary drug discovery platform designed to identify novel small molecules that induce selective degradation of drug target proteins through E3 ligase mediated proteasomal degradation. From molecular glues to monovalent degraders, Plexium is advancing a pipeline of novel targeted protein degraders for the treatment of cancer, neurodegeneration, and other diseases.
|
|
|
51-200 employees
View all Plexium employees
|
|
Biotechnology
|
|
11494 Sorrento Valley Rd, San Diego, California 92121, US
|
|
2018
|
Plexium Alternatives
Frequently Asked Questions about Plexium
The decision makers in Plexium are Adam Hill, Daniel Sipes, Kevin Freeman-cook, etc. Click to Find Plexium decision makers emails.
Plexium Staff Directory
Search Plexium Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
